BIOEMTECH

🚀 Over the past few years, we have seen our Workshop in the field of Drug and Radioligand Therapy grown in size, providing networking and knowledge sharing opportunities for all attendees. This year's 4th Annual BIOEMTECH’s Preclinical Workshop programme included presentations on key topics from some of the most established scientists in the field. 🔬 We also had a full day of hands-on experience in our boutique laboratories, covering radiochemistry, model preparation, in vivo imaging and post-processing issues.    Each year we accept the challenge of organizing a scientific meeting of high quality that will deliver additional and valuable information to the  radiotheranostic community. 📣 We are very pleased to already invite you to our next 5th  Workshop from 30 of September to 3 of October 2025. 📣 We are waiting with great anticipation to see you again in Athens.    #preclinicalresearch, #molecularimaging, #drugdiscovery, #pharmaceuticalresearch, #nuclearmedicine, #oncology, #radiopharmaceuticals Take a look on this years video!! 👇

👨🔬 Science Letter #️⃣ Νο2 @ BIOEMTECH’s Knowledge Hub 👉 https://lnkd.in/dmn4HvZc 📆 In this month's edition, we are pleased to publish an article from our long-term collaborator Mattia Asti, on the subject of "Chelators for the next generation of Theranostic Soft Radiometals" ☢️ . Mattia is a highly accomplished biochemist with considerable experience in the synthesis, pre-clinical evaluation and preparation of radiopharmaceuticals, as well as in the development of new radioligands. 👇 🔬 According to #Pearson's HSAB theory, chemical species can be classified as either "hard" or "soft", based on certain intrinsic properties. While the majority of the commonly used radiometals are classified as "hard", several promising potential theranostic radionuclides, fall into the "soft" or "intermediate" categories. The HSAB theory can provide valuable insight into the design of effective chelators for radiometals . Known chelators are highly effective in encapsulating commonly used radiometal ions. This concept was highlighted by comparing the performance of #DOTA, with that of modified DOTA derivatives. As a result, the performance of DOTA can be significantly enhanced. In particular, a strong correlation was observed between the chemical softness of the radiometals and their corresponding chelators, which further validates the utility of the HSAB theory in the design of new chelating scaffolds. #TheranosticSoftRadiometals, #HSABtheory, #ScienceLetters, #KnowledgeHub, #DrugDiscovery, #Radiopharmaceutics

At BIOEMTECH, we have an inherent passion for sharing knowledge. It is what drives us to organise our Annual Workshop and what made us aspire a specific science spot in our website, where someone can just read scientific reports and be scientifically updated on what is happening in the exciting field of Drug Discovery & Targeted Radioligand Therapy. This is why we are launching the Knowledge Hub 🧠 - each month we will be uploading a new "Science Letter" 👩🔬 , created by our collaborators, sponsors and team members. You can already read the first one, by Janke Kleynhans, on "Working with Actinium-225". 👉 https://lnkd.in/dmf4SeFh #ScienceLetters, #KnowledgeHub, #DrugDiscovery, #Radiopharmaceutics, #Actinium

In BIOEMTECH we are more than happy to contribute to this #HPC Training Series by EuroCC@Greece. Valentina Paneta and Vasilis Eleftheriadis will provide a #tutorial on "AI / DL in Healthcare Imaging -- Tutorial using MONAI and PyRadiomics". Don't miss the chance to attend the #training course on #AI in Healthcare and Life Sciences. 📅 Date: November 1st, 2024 📍Online🌐: Zoom ✍ Registration: Free #BIOEMTECH, #radiomics, #Deeplearning, #AI, #healthcare, #Pyradiomics, #MONAI

Small Size, Big Impact! 🧪 At just 44cm x 46cm, the γ-eye™ is your benchtop solution for advanced SPECT imaging. Turn any space into a cutting-edge lab! \#LabLife \#SPECTImaging Learn more: https://lnkd.in/gE6B_M4a

👩🔬 The 4th Annual BIOEMTECH's Preclinical Workshop drew to a close today with one last session on #Molecules. We would like to thank Theodoros Karampelas for his presentations and for moderating the panel discussion on “Targets & Therapies”, Jacob Hesterman and Olof Eriksson for their presentations, and finally Jeff Norenberg for joining in the panel discussion.   ✨ At the closing session there was a lot of excitement, and we committed to returning next year even more engaged in embracing scientists translate ideas into outcomes.   👏 A big round of applause to our workshop host, Katerina Argyropoulou, who kept everything running smoothly always with a smile on her face.   🍴 🍷 Before saying goodbye to all our attendees and speakers, we had the chance to have lunch and some farewell drinks, relax a little bit and chat, making our farewells a more memorable experience. This was a great week for us!   #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🧑🎓 Today we delved deeper into subjects such as "Molecules in Drug Discovery and Regulatory" and "Operating Aspects of Preclinical/Clinical Studies" with 2 very interesting sessions. Each session was followed by a stimulating panel discussion on the crucial topic of “Choosing the right molecule” and the vital subject of “GLP & procedures”.   🙏 We would like to thank Jeff Norenberg for the opening presentation and for moderating the 1st panel discussion, Anne Bredenbeck, Federico Maisano for their nice presentations and SUJIET PUTHENVEETIL for participating in the panel discussion. We would also like to thank Irving Allen, Monique Bernsen for their presentations and finally Argyro Zacharioudaki for her presentation and moderation of the 2nd panel discussion.   🥂 We've got one last day of the 4th Annual BIOEMTECH's Preclinical Workshop tomorrow with one more #Molecules session on the agenda. After that, we'll have the closing ceremony with some farewell drinks. #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎊 3rd day of the 4th Annual BIOEMTECH’s Preclinical Workshop and today we had visitors in our Laboratories! It was a day full of hands-on experience and deep practical knowledge in #Radiation_protection, #Model_development, #Radio_compound_preparation, #Anesthesia_preparation, #Compound_administration and #Image_acquisition. 🤝 Special thanks to PD Dr. Felix Gremse, for his presentation on #Postprocessing. We are pleased to announce the forthcoming collaboration between Gremse-IT and BIOEMTECH, to provide state-of-the-art quantification analysis of preclinical imaging studies using #ImalyticsPreclinical software.   🔭 In the afternoon we had some time to relax with dinner and drinks in downtown Athens, followed by a guided tour of the National Observatory of Athens. Always take the opportunity to go stargazing...         #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎉 Today was the 2nd day of the 4th Annual BIOEMTECH's Preclinical Workshop and we continued to dive into the understanding and realisation of the major and most novel issues of the Drug and Radioligand Therapy field.     📅 The program started with the Isotopes & Cells session with Mattia Asti, Marion Malenge and Antonios Skliris. Then we had the Radiolabelling session with Janke Kleynhans and Sophia Sarpaki, PhD and our panel with Eliza Lambidis, PhD moderating. Finally, we had the Dosimetry session with Panagiotis Papadimitroulas, PD Dr. Felix Gremse and Dr. Michel Afargan with the closing lecture of the day. We would really like to thank all session speakers and panelists for their contributions.   🔬 Tomorrow is the Hands-On session! We look forward to welcoming all the workshop participants to our headquarters.     #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎉 The 4th Annual BIOEMTECH's Preclinical Workshop has started today, bringing together scientists from the Drug Discovery & Targeted Radioligand Therapy community. This will be a full week of inspiring talks and meaningful discussions with people from academia and industry in the field of drug discovery and targeted radioligand therapy.   🤝 Today we kicked off Workshop Day 1 with the Imaging Modalities and Non-Oncology Models sessions. We would like to thank Syed Nuruddin, PhD, Justin Jeffery, Thomas Wanek, Ingrid Yao Mattisson, PhD, Alice Zoro for their insightful presentations. Special thanks also to Pradip Chaudhari for moderating our panel discussion.   📰 We continue tomorrow with three more sessions: Isotopes & Cells, Radiolabelling and Dosimetry. Stay tuned...     #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals